Vialwirebiotech, curated
October 1, 2026, 6:43 AM
August 6, 2026
- 6:30 AM · Bloomberg — Technology6:30 AMRoche Uses Recursion AI to Uncover New Brain Disease Targets — Bloomberg — Technology
- 6:18 AM · Pharmaceutical Technology6:18 AMEli Lilly raises 2026 outlook again as Q2 soars past estimates — Pharmaceutical Technology
- 5:36 AM · Pharmaceutical Technology5:36 AMAlteogen signs $365m Hybrozyme licensing deal with pharma company — Pharmaceutical Technology
- 5:01 AM · Pharmaceutical Technology5:01 AMSchrödinger and BMS expand partnership to deploy AI for drug discovery — Pharmaceutical Technology
- 5:01 AM · SCMP — Tech5:01 AMChina adds US sanctions, drone curbs in trade tit-for-tat — SCMP — Tech
- 5:00 AM · Drug Discovery World5:00 AMMerger creates CNS biopharma worth $2.2 billion — Drug Discovery World
- 12:25 AM · SCMP — Tech12:25 AMSouth Korean biotech bets on donated human fat product to fix ‘Ozempic face’ — SCMP — Tech
August 5, 2026
- 10:18 PM · STAT News10:18 PMFDA approves Moderna’s mRNA flu vaccine, the first to use the technology — STAT News
- 1:46 PM · STAT News
- 12:00 PM · BioWorld12:00 PMAttovia so: IPO spree real, $289M in upsized bid — BioWorld
- 12:00 PM · BioWorld12:00 PMSenators explore ways to step up innovation in US biotech sector — BioWorld
- 12:00 PM · BioWorld12:00 PMMestrualia secures CE mark for Sobek diagnostic platform — BioWorld
- 12:00 PM · BioWorld12:00 PM340B rebate pilot model 2.0 seeking Rx recruits — BioWorld
- 11:22 AM · Pharmaceutical Technology11:22 AMNovo Nordisk not currently in a position to pursue large-scale M&A, CEO says — Pharmaceutical Technology
- 9:37 AM · Pharmaceutical Executive9:37 AM<![CDATA[CSPC Pharmaceutical & AstraZeneca Form Joint Venture for Biologics Manufacturing in China]]> — Pharmaceutical Executive
- 9:08 AM · PharmaVoice9:08 AMFDA allows unique endpoint in rare disease study — PharmaVoice
- 9:00 AM · BioWorld9:00 AMReceptor.AI and Sethera establish discovery collaboration — BioWorld
- 9:00 AM · BioWorld9:00 AMRecursion’s PI3Kα H1047R inhibitor REC-7735 cleared for clinic — BioWorld
- 9:00 AM · BioWorld9:00 AMFDA clears IND for Brightpath’s BP-2202 for multiple myeloma — BioWorld
- 8:00 AM · BioPharma Dive8:00 AMA COPD drug from China draws $115M in venture funding — BioPharma Dive
- 6:44 AM · Drug Discovery World6:44 AMPhase I trial “a major step forward” against Ebola outbreak — Drug Discovery World
- 4:59 AM · Pharmaceutical Technology4:59 AMAsymBio to secure $184m to support growth in biologics manufacturing — Pharmaceutical Technology
- 4:30 AM · STAT News
- 4:25 AM · Pharmaceutical Technology4:25 AMPhylo and Chugai collaborate to deploy AI platform in drug discovery — Pharmaceutical Technology
- 2:18 AM · Science (News)2:18 AMNIH Director Bhattacharya kills more health disparities grants — Science (News)
August 4, 2026
- 9:45 PM · Nikkei Asia9:45 PMTakeda aims for dengue vaccine inclusion in India's shots program — Nikkei Asia
- 7:00 PM · Bloomberg — Technology7:00 PMLab Monkeys for $26,000 Show China’s Biotech Quest to Rival US — Bloomberg — Technology
- 1:04 PM · STAT News
- 12:19 PM · BioPharma Dive12:19 PMVertex’s biggest overhang: a rival 50 times smaller — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMAPRIL flowers for Otsuka in IgAN; Vertex’s plus-BAFF last laugh? — BioWorld
- 12:00 PM · BioWorld12:00 PMImunexus platform adds a new twist to bispecific development — BioWorld
- 12:00 PM · BioWorld12:00 PMPathos AI, Alphamab in $2B+ deal for TROP2/HER3 ADC — BioWorld
- 12:00 PM · BioWorld12:00 PMUS-based Ingenia plans $42M Kosdaq IPO for TIE2 pipeline — BioWorld
- 12:00 PM · BioWorld12:00 PMAB2 Bio triggers $30M milestone as Nippon Shinyaku takes up US option — BioWorld
- 11:55 AM · BioPharma Dive11:55 AMPfizer expands multibillion-dollar cost-cutting plan — BioPharma Dive
- 10:20 AM · BioPharma Dive10:20 AMJ&J pharma leader to retire; Krystal slumps on gene therapy miss — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMNiagen Bioscience partners with Evotec to advance NB-4168 — BioWorld
- 9:00 AM · BioWorld9:00 AMSatellite Biosciences’ SB-101 gains IND clearance — BioWorld